Creative Net Income Per Share from 2010 to 2026

CELZ Stock  USD 1.78  0.19  9.64%   
Creative Medical Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss will likely drop to -4.48 in 2026. During the period from 2010 to 2026, Creative Medical Net Loss regression line of annual values had significance of  0.62 and arithmetic mean of (2,617). View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(4.27)
Current Value
(4.48)
Quarterly Volatility
4.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Creative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creative Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 3.9 M, Other Operating Expenses of 6.9 M or Total Operating Expenses of 6.9 M, as well as many indicators such as Price To Sales Ratio of 159, Dividend Yield of 0.0 or PTB Ratio of 0.65. Creative financial statements analysis is a perfect complement when working with Creative Medical Valuation or Volatility modules.
  
Build AI portfolio with Creative Stock
Check out the analysis of Creative Medical Correlation against competitors.
The evolution of Net Income Per Share for Creative Medical Technology provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Creative Medical compares to historical norms and industry peers.

Latest Creative Medical's Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of Creative Medical Technology over the last few years. It is Creative Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Creative Medical's overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Pretty Stable
   Net Income Per Share   
       Timeline  

Creative Net Income Per Share Regression Statistics

Arithmetic Mean(2,617)
Coefficient Of Variation(183.32)
Mean Deviation3,275
Median(1,002)
Standard Deviation4,797
Sample Variance23M
Range17.5K
R-Value0.13
Mean Square Error24.1M
R-Squared0.02
Significance0.62
Slope123.03
Total Sum of Squares368.1M

Creative Net Income Per Share History

2026 -4.48
2025 -4.27
2024 -3.71
2023 -3.76
2022 -9.28
2021 73.75
2020 -626.88

About Creative Medical Financial Statements

Creative Medical investors use historical fundamental indicators, such as Creative Medical's Net Income Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Creative Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss(4.27)(4.48)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.